A proposed framework to evaluate the quality and reliability of targeted metabolomics assays from the UK Consortium on Metabolic Phenotyping (MAP/UK). (2023)
Attributed to:
UK Consortium for MetAbolic Phenotyping (MAP UK)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41596-022-00801-8
PubMed Identifier: 36828894
Publication URI: http://europepmc.org/abstract/MED/36828894
Type: Journal Article/Review
Volume: 18
Parent Publication: Nature protocols
Issue: 4
ISSN: 1750-2799